霉菌毒素检测市场 - 全球产业规模、份额、趋势、机会及预测（按类型、技术、样本、最终用户、地区和竞争格局划分，2021-2031年）

全球霉菌毒素检测市场预计将从 2025 年的 144.6 亿美元成长到 2031 年的 223.9 亿美元，复合年增长率为 7.56%。

霉菌毒素检测是指用于识别和测量农作物和加工食品中真菌产生的有毒次级代谢物的分析通讯协定。该市场的成长主要受严格的国际食品安​​全标准和不断增长的全球贸易量驱动，这些标准和贸易量要求严格遵守最大残留基准值。此外，气候条件不稳定导致真菌污染日益频繁，也是推动常规检测措施实施的关键因素。

儘管市场需求强劲，但先进层析法设备所需的高额资本投入以及复杂的样品製备过程，对发展中地区的市场成长构成了重大障碍。准确的数据对于有效的风险管理策略仍然至关重要。正如2024年发布的《2023年预警与合作网络年度报告》所述，霉菌毒素仍然是一个重要的安全隐患，欧洲网络共记录了401起相关报告，使其成为报告数量第三多的危险物质类别。

市场驱动因素

气候变迁对作物霉菌易感性的影响日益加剧，是全球霉菌毒素检测市场的主要驱动因素。从长期干旱到暴雨等极端天气事件，为农产品中真菌的生长创造了理想条件，因此需要更频繁、更全面的分析。随着供应链面临日益增长的污染风险，该行业依赖数据来预测和管理这些生物危害。根据帝斯曼-菲美意公司于2025年3月发布的《全球霉菌毒素调查报告》，六种主要霉菌毒素的检出率上年度上升，北美和南亚等地区被列为「极高」风险等级。这迫使生产商实施严格的筛检，以确保原料在加工过程中保持安全。

对高品质饲料日益增长的需求以及减少收穫后污染造成的经济损失的迫切需要，进一步推动了市场对相关技术的应用。多种毒素同时存在（即霉菌毒素共存）会对牲畜构成严重的健康风险，因此，为了维持畜群生产力，人们开始转向采用先进的多毒素检测方法。嘉吉公司在2025年3月世界霉菌毒素论坛上发布的《全球霉菌毒素报告》显示，霉菌毒素共存仍是一个重大挑战，在78%的受检饲料样本中检测到三种或三种以上的霉菌毒素。这项业务需求为检测服务提供者带来了显着的财务效益。根据Neogen公司2025年的数据显示，食品安全部门的收入占公司年度总收入的71.3%，证实了该行业的强劲商业性成长。

市场挑战

先进层析法设备所需的巨额资本投入，构成了全球霉菌毒素检测市场扩张的一大结构性障碍。液相层析法质谱仪等尖端检测系统对于达到识别微量污染所需的灵敏度至关重要。然而，这项技术高昂的购买和营运成本，对小规模实验室和食品加工企业，尤其是在开发中国家，构成了很高的进入门槛。这种经济负担限制了自动化检测通讯协定的应用，使其仅限于已开发国家资源充足的机构，从而有效地抑制了新兴市场的需求，而这些新兴市场往往面临最大的真菌污染风险。

此外，样品製备的复杂性需要专用设备和高技能人员，这增加了营运成本。这种技术上的独占性使得小规模农业相关企业无法进行常规的内部检测，迫使它们依赖第三方服务或干脆放弃检测。贸易合规数据也印证了这种严格且高成本的检测需求。根据美国谷物协会发布的《2024年玉米作物品质报告》，98.9%的受检样本符合联邦政府严格的黄曲毒素基准值。这种以金额为准的精确合规性确认需要精密的设备，而这些设备对于许多市场参与企业来说仍然遥不可及，从而限制了检测解决方案的潜在市场规模。

市场趋势

对新兴和隐藏霉菌毒素的监测力道加大，正从根本上重塑市场分析策略。监管机构和行业相关人员正在扩大检测范围，超越传统的受监管化合物，以检测标准筛检常常遗漏的变异株和鲜为人知的真菌代谢物。这种转变的驱动力在于，人们需要全面了解饲料和食品基质的毒理学负担，尤其是在非管制毒素日益普遍的情况下。根据专利公司于2025年2月进行的“2024年收成调查”，从多个欧洲国家采集的玉米样本100%都受到多种霉菌毒素的污染，除了受监管的化合物外，新兴毒素（例如博维菌素）也被确定为主要污染物。

同时，检测资料的数位化和可追溯性的建立正成为应对供应链安全复杂性的关键趋势。检测实验室和食品加工商正在加速整合人工智慧和云端平台，以汇总检测结果、预测污染风险并确保即时合规。这项技术变革正推动产业从被动侦测转向主动风险情报，从而在问题出现时能够更快地做出决策。根据SGS于2025年2月发布的《Digicomply威胁情报洞察报告》，在过去24个月中，霉菌毒素一直位列全球报告的三大食品安全危害之一，这凸显了人们越来越依赖数位化工具来监测这些生物威胁。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球霉菌毒素检测市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 依类型（黄曲毒素、Deoxynivalenol、赭曲毒素、Fumonisins、其他）
  • 依技术分类（基于高效液相层析法、基于液相层析-串联质谱法、基于免疫检测、其他）
  • 按样本（食品、饲料）
  • 按最终用户（研究实验室、研究机构、食品检测产业、饲料检测产业等）
  • 按地区
  • 按公司（2025 年）
• 市场地图

6. 北美霉菌毒素检测市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲霉菌毒素检测市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

8. 亚太地区霉菌毒素检测市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

9. 中东和非洲霉菌毒素检测市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

10. 南美霉菌毒素检测市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球霉菌毒素检测市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• SGS Societe Generale de Surveillance SA.
• Bureau Veritas
• Eurofins Scientific
• Intertek Group plc
• Merieux NutriSciences Corporation
• ALS Limited
• Neogen Corporation
• AsureQuality Limited.
• Charm Sciences, Inc.
• Premier Analytical Services

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Mycotoxin Testing Market is projected to expand from USD 14.46 Billion in 2025 to USD 22.39 Billion by 2031, reflecting a compound annual growth rate of 7.56%. Mycotoxin testing involves the analytical protocols used to identify and measure toxic secondary metabolites generated by fungi in agricultural crops and processed foods. The market is primarily driven by the implementation of rigorous international food safety standards and the increasing volume of global trade, which mandates strict adherence to maximum residue limits. Furthermore, the rising frequency of fungal contamination caused by unstable climate conditions acts as a key catalyst for the adoption of routine testing measures.

Despite strong demand, the substantial capital required for advanced chromatographic equipment and the complexity of sample preparation pose major hurdles to market growth in developing regions. Accurate data remains essential for effective risk management strategies. As noted in the Alert and Cooperation Network 2023 Annual Report released in 2024, mycotoxins continued to be a significant safety concern, ranking as the third most reported hazard category with 401 notifications documented across the European network.

Market Driver

The intensifying impact of climate change on crop vulnerability to mold serves as a primary driver for the Global Mycotoxin Testing Market. Extreme weather patterns, ranging from prolonged droughts to excessive rainfall, create ideal conditions for fungal proliferation in agricultural commodities, necessitating more frequent and comprehensive analysis. As supply chains face elevated contamination risks, the industry relies on data to forecast and manage these biological hazards. According to the 'World Mycotoxin Survey' by dsm-firmenich in March 2025, the prevalence of all six major mycotoxins increased compared to the previous year, with risk levels classified as extreme in regions such as North America and South Asia, compelling producers to adopt strict screening to ensure raw materials remain safe for processing.

The rising demand for high-quality animal feed and the critical need to mitigate economic losses from post-harvest contamination further stimulate market adoption. Mycotoxin co-occurrence-where multiple toxins exist simultaneously-poses severe health risks to livestock, driving the shift toward advanced multi-toxin detection methods to preserve herd productivity. Findings from the 'World Mycotoxin Report' presented by Cargill at the World Mycotoxin Forum in March 2025 highlight that co-occurrence remains a major challenge, with 78% of tested feed samples containing three or more mycotoxins. This operational necessity drives significant financial performance for testing providers; according to Neogen Corporation in 2025, the Food Safety segment contributed 71.3% of the company's total annual revenues, underscoring the sector's robust commercial expansion.

Market Challenge

The substantial capital investment required for sophisticated chromatographic instruments constitutes a significant structural impediment to the broader expansion of the global mycotoxin testing market. State-of-the-art detection systems, such as liquid chromatography-mass spectrometry, are essential for achieving the sensitivity needed to identify trace contamination levels. However, the high procurement and operational costs associated with this technology create a steep entry barrier for small-scale laboratories and food processors, particularly in developing economies. This financial burden restricts the adoption of automated testing protocols to well-funded organizations in industrialized nations, effectively stifling demand in emerging markets where the risk of fungal contamination is often highest.

Additionally, the complexity of sample preparation demands specialized infrastructure and highly skilled personnel, which adds to the operational expenditure. This technical exclusivity prevents smaller agricultural entities from implementing routine internal testing, forcing them to rely on third-party services or forgo testing entirely. The necessity for such rigorous, high-cost testing is evident in trade compliance data. According to the U.S. Grains Council's 2024 Corn Harvest Quality Report, 98.9% of tested samples met strict federal action levels for aflatoxin. Verifying compliance at such precise thresholds requires sophisticated instrumentation that remains financially inaccessible to many market participants, thereby capping the total addressable market for testing solutions.

Market Trends

The increased surveillance of emerging and masked mycotoxins is fundamentally reshaping analytical strategies within the market. Regulatory bodies and industry players are expanding testing panels beyond traditional regulated compounds to detect modified forms and lesser-known fungal metabolites that standard screening often misses. This shift is driven by the need to understand the full toxicological burden of feed and food matrices, particularly as non-regulated toxins become more prevalent. According to the '2024 Harvest Survey' by Patent Co in February 2025, 100% of corn samples analyzed from multiple European nations were contaminated with more than one mycotoxin type, with emerging toxins such as beauvericin identified as primary contaminants alongside regulated compounds.

Concurrently, the digitalization of testing data and traceability is emerging as a critical trend to manage the complexity of supply chain safety. Laboratories and food processors are increasingly integrating artificial intelligence and cloud-based platforms to aggregate testing results, predict contamination risks, and ensure real-time regulatory compliance. This technological transition moves the industry from reactive testing to proactive risk intelligence, allowing for faster decision-making during outbreaks. According to SGS in its 'Digicomply' risk intelligence insights from February 2025, mycotoxins persisted as one of the top three reported food safety hazards globally over the preceding 24 months, underscoring the reliance on digital tools to monitor these biological threats.

Key Market Players

• SGS Societe Generale de Surveillance SA.
• Bureau Veritas
• Eurofins Scientific
• Intertek Group plc
• Merieux NutriSciences Corporation
• ALS Limited
• Neogen Corporation
• AsureQuality Limited.
• Charm Sciences, Inc.
• Premier Analytical Services

Report Scope

In this report, the Global Mycotoxin Testing Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Mycotoxin Testing Market, By Type

• Aflatoxin
• Deoxynivalenol
• Ochratoxins
• Fumonisins
• Others

Mycotoxin Testing Market, By Technology

• HPLC-based
• LC-MS/MS-based
• Immunoassay-based
• Others

Mycotoxin Testing Market, By Sample

• Food
• Feed

Mycotoxin Testing Market, By End User

• Research Lab
• Research Institutes
• Food Testing Industries
• Feed Testing Industries
• Others

Mycotoxin Testing Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Mycotoxin Testing Market.

Available Customizations:

Global Mycotoxin Testing Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Mycotoxin Testing Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Aflatoxin, Deoxynivalenol, Ochratoxins, Fumonisins, Others)
  • 5.2.2. By Technology (HPLC-based, LC-MS/MS-based, Immunoassay-based, Others)
  • 5.2.3. By Sample (Food, Feed)
  • 5.2.4. By End User (Research Lab, Research Institutes, Food Testing Industries, Feed Testing Industries, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America Mycotoxin Testing Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Technology
  • 6.2.3. By Sample
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Mycotoxin Testing Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Technology
      • 6.3.1.2.3. By Sample
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada Mycotoxin Testing Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Technology
      • 6.3.2.2.3. By Sample
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico Mycotoxin Testing Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Technology
      • 6.3.3.2.3. By Sample
      • 6.3.3.2.4. By End User

7. Europe Mycotoxin Testing Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Technology
  • 7.2.3. By Sample
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Mycotoxin Testing Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Technology
      • 7.3.1.2.3. By Sample
      • 7.3.1.2.4. By End User
  • 7.3.2. France Mycotoxin Testing Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Technology
      • 7.3.2.2.3. By Sample
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom Mycotoxin Testing Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Technology
      • 7.3.3.2.3. By Sample
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy Mycotoxin Testing Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Technology
      • 7.3.4.2.3. By Sample
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Mycotoxin Testing Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Technology
      • 7.3.5.2.3. By Sample
      • 7.3.5.2.4. By End User

8. Asia Pacific Mycotoxin Testing Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Technology
  • 8.2.3. By Sample
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Mycotoxin Testing Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Technology
      • 8.3.1.2.3. By Sample
      • 8.3.1.2.4. By End User
  • 8.3.2. India Mycotoxin Testing Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Technology
      • 8.3.2.2.3. By Sample
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan Mycotoxin Testing Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Technology
      • 8.3.3.2.3. By Sample
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea Mycotoxin Testing Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Technology
      • 8.3.4.2.3. By Sample
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Mycotoxin Testing Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Technology
      • 8.3.5.2.3. By Sample
      • 8.3.5.2.4. By End User

9. Middle East & Africa Mycotoxin Testing Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Technology
  • 9.2.3. By Sample
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Mycotoxin Testing Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Technology
      • 9.3.1.2.3. By Sample
      • 9.3.1.2.4. By End User
  • 9.3.2. UAE Mycotoxin Testing Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Technology
      • 9.3.2.2.3. By Sample
      • 9.3.2.2.4. By End User
  • 9.3.3. South Africa Mycotoxin Testing Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Technology
      • 9.3.3.2.3. By Sample
      • 9.3.3.2.4. By End User

10. South America Mycotoxin Testing Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Technology
  • 10.2.3. By Sample
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Mycotoxin Testing Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Technology
      • 10.3.1.2.3. By Sample
      • 10.3.1.2.4. By End User
  • 10.3.2. Colombia Mycotoxin Testing Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Technology
      • 10.3.2.2.3. By Sample
      • 10.3.2.2.4. By End User
  • 10.3.3. Argentina Mycotoxin Testing Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Technology
      • 10.3.3.2.3. By Sample
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Mycotoxin Testing Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. SGS Societe Generale de Surveillance SA.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Bureau Veritas
• 15.3. Eurofins Scientific
• 15.4. Intertek Group plc
• 15.5. Merieux NutriSciences Corporation
• 15.6. ALS Limited
• 15.7. Neogen Corporation
• 15.8. AsureQuality Limited.
• 15.9. Charm Sciences, Inc.
• 15.10. Premier Analytical Services

16. Strategic Recommendations

17. About Us & Disclaimer